Physician profile
Peter Dipasco
NPI 1659491314
$246,626.26
in general payments reported to CMS, 2019-2025
65 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $28K · 2021: $40K · 2022: $24K · 2023: $26K · 2024: $65K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $126K · Travel and Lodging: $7,297 · Food and Beverage: $6,472 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $125,773.78 |
| Travel and Lodging | $7,297.18 |
| Food and Beverage | $6,471.50 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $149,368.59 | 2019-2025 | Neuflex, Zip Pen, Megadyne |
| Ethicon US, LLC | $53,906.73 | 2019-2025 | Certus 140, Megadyne, Vistaseal |
| Ethicon INC. | $25,037.36 | 2019-2025 | Certus 140 |
| Ethicon Endo-Surgery INC. | $12,358.27 | 2023-2024 | Neuflex, Certus 140 |
| Histosonics, INC. | $938.96 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $368.78 | 2022-2025 | Libtayo |
| Janssen Biotech, INC. | $312.06 | 2021-2025 | Tecvayli, Talvey, Darzalex |
| Hologic Sales and Service, LLC | $306.13 | 2024-2025 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $294.18 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Tempus Ai, INC | $251.10 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $235.24 | 2021-2025 | Imfinzi, Calquence, Enhertu |
| Daiichi Sankyo INC. | $218.87 | 2022-2025 | Enhertu, Injectafer |
| Intera Oncology, INC | $175.02 | 2024 | Intera |
| Stryker Corporation | $173.18 | 2024 | Stryker |
| Dilon Technologies, INC. | $156.31 | 2025 | Hemoblast Bellows |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $154.07 | 2023-2025 | Polivy, Tecentriq, Lunsumio |
| Pfizer INC. | $140.80 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.14 | 2022-2025 | Iclusig, Fruzaqla, Alunbrig |
| Abbvie INC. | $127.31 | 2021-2025 | Venclexta |
| Incyte Corporation | $126.38 | 2020-2025 | Jakafi, Niktimvo, Monjuvi |
| Novo Nordisk INC | $125.00 | 2022 | |
| Seagen INC. | $119.69 | 2021-2023 | Tukysa |
| Amgen INC. | $108.66 | 2021-2023 | Lumakras, Nplate, Xgeva |
| Novartis Pharmaceuticals Corporation | $106.52 | 2022-2024 | |
| Siemens Medical Solutions USA, INC. | $105.81 | 2025 | Microthermx Microwave Ablation System |
| Lilly USA, LLC | $92.52 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $80.63 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.52 | 2023-2024 | |
| Taiho Oncology, INC. | $69.32 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $68.85 | 2021-2023 | Myrisk |
| Puma Biotechnology, INC. | $59.17 | 2021-2024 | |
| Genzyme Corporation | $47.75 | 2022-2023 | |
| Springworks Therapeutics, INC. | $47.39 | 2025 | Ogsiveo |
| Mirati Therapeutics, INC. | $41.81 | 2023-2024 | Krazati |
| Sobi, INC | $40.70 | 2022-2025 | |
| Kyowa Kirin, INC. | $40.66 | 2021-2023 | Poteligeo |
| Adc Therapeutics America, INC. | $39.66 | 2022-2023 | |
| Blueprint Medicines Corporation | $39.32 | 2022-2023 | Ayvakit |
| Servier Pharmaceuticals LLC | $34.78 | 2021-2024 | |
| Global Blood Therapeutics, INC. | $32.44 | 2021-2022 | |
| Galvanize Therapeutics, INC | $29.24 | 2023 | Aliya System |
| Ets Wound Care LLC | $29.16 | 2024 | Mirragen Advanced Wound Matrix |
| Astellas Pharma US INC | $27.50 | 2025 | Vyloy |
| G1 Therapeutics, INC. | $22.02 | 2023 | Cosela |
| Intuitive Surgical, INC. | $21.90 | 2022 | |
| Beigene USA, INC. | $21.83 | 2025 | Tevimbra |
| Medtronic, INC. | $21.52 | 2025 | Emprint |
| Blue Earth Diagnostics | $20.67 | 2021 | |
| Immunogen, INC. | $19.98 | 2023 | Elahere |
| Emd Serono, INC. | $19.96 | 2021 | |
| Octapharma USA, INC. | $19.28 | 2024 | Octagam Immune Globulin (Human) |
| Aveo Pharmaceuticals, INC. | $18.52 | 2025 | |
| Morphosys, US INC. | $18.22 | 2021 | |
| Coherus Oncology, INC. | $17.68 | 2021 | |
| Dova Pharmaceuticals | $17.56 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.82 | 2021 | |
| Melinta Therapeutics, LLC | $16.28 | 2024 | Kimyrsa, Rezzayo |
| Tersera Therapeutics LLC | $16.02 | 2023 | Zoladex |
| Pharmacosmos Therapeutics INC. | $15.97 | 2024 | Cosela |
| Emmaus Medical, INC. | $15.51 | 2024 | Endari |
| Gilead Sciences, INC. | $14.57 | 2025 | Trodelvy |
| Epizyme, INC. | $13.33 | 2021 | |
| Adaptive Biotechnologies Corporation | $12.91 | 2021 | |
| Sun Pharmaceutical Industries INC. | $12.36 | 2021 | |
| Pharmaand Gmbh | $11.77 | 2025 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Dipasco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.